Now livetag icon
Last chance: Join our AI Brand Visibility webinar with industry leaders Aleyda Solis and Rand Fishkin!Secure your spot nowbanner icon
InflaRx

June 2026

InflaRx Market Share Analysis for June 2026

Year Founded2007
Employees51 - 200
Annual Revenue$15M - $25M
inflarx.de
InflaRx
InflaRx (including company regionals)
  • inflarx.de
    inflarx.de
See more website traffic and engagement information

InflaRx Revenue up to June 2026 is 15M - 25M

revenue generated by InflaRx top domains

InflaRx top domains revenue over 3 years

Revenue for InflaRx top domains


Total visits to InflaRx's top domains

Understand InflaRx market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

Avg. visit duration in InflaRx's top domains

Analyze InflaRx engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

Avg. pageviews on InflaRx's top domains

See how InflaRx keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

Want to gain deeper traffic insights?

Filter 20.3M+ online businesses. Discover new leads when their traffic spikes, when they start or stop using technologies, or when they get positive press.


InflaRx top competitors by domain

Looks like there’s not enough data here

No Data to Display

Benchmark Your Digital Performance

Identify high-value opportunities, track your performance, and win your market.


Top technologies used by InflaRx

These are the website technologies, by industry, used by InflaRx top domains

Conversion & Analytics (2)

Google Analytics

Google Analytics

Email Services (2)

Microsoft Exchange Online

Microsoft Exchange Online

Advertising (1)

DoubleClick

DoubleClick

Audio Video Media (1)

VideoJS

VideoJS

More Technologies

8

See all

Ready to discover high quality prospects?

Identify what technologies a website uses to craft the perfect sales pitch, and shorten the sales cycle with the Similarweb Sales Intelligence Solution.


News & Signals from InflaRx

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsZwick left InflaRx GmbH as Senior Vice President and Chief Strategy Officer on Jun 11th '26.Mr. Zwick served as Senior Vice President, Corporate Business Development and Investor Relations at Amarin Corporation and, previously, as Senior Vice President and Chief Strategy Officer at InflaRx N.V.
NewsInflaRx GmbH is developing izicopan, an oral C5a receptor inhibitor.InflaRx N.V. (Nasdaq: IFRX) has announced its strategic focus on developing izicopan, an oral C5a receptor (C5aR) inhibitor, for the treatment of ANCA-associated vasculitis (AAV) and other life-threatening renal diseases.
NewsInflaRx GmbH received financing of $150M in underwritten offering on May 7th '26.InflaRx announces closing of $150 million underwritten offering of ordinary shares.

See all InflaRx signals

Focus your sales teams on the most promising opportunities. By prioritizing opportunities and engaging at the right time, you can optimize efforts and close more deals.